| Open | 1667.6 |
| LTP | 1618.35 |
| Previous Close | 1682.9 |
| Day High | 1670.05 |
| Day Low | 1602.2 |
| Volume | 121857 |
| Code : | MTARTECH |
| Name : | Mtar Technologies Limited |
| Country : | India |
| Sector : | Aerospace & Defence |
| Industry: | Specialty Industrial Machinery |
| Market CAP : | 5,056 Cr |
| Stock P/E: | 129.88 |
| ROCE: | 5.66% |
| Book Value: | 227.3 |
| Dividend Yield : | 0% |
| Most Recent Quarter : | 2024-09-30 |
| Revenue/Sales TTM : | 580 Cr |
| Operating Margin TTM : | 0.1527% |
| Return On Equity TTM : | 0.06% |
| Profit Margin : | 0.07% |
| Market Capitalization : | 5,056 Cr |
| EBITDA : | 95 Cr |
| Book Value : | 227.3 |
| PERatio : | 129.88 |
| Dividend Share : | |
| Earnings Share : | 12.45 |
| Gross Profit TTM : | 271 Cr |
| Quarterly Earnings Growth YOY : | -0.08% |
| Dividend Yield : | % |
| Quarterly Revenue GrowthYOY : | 0.14 |
| Diluted Eps TTM : | 12.45 |
| Trailing PE : | 129.88 |
| Price Sales TTM : | 8.72 |
| Enter Prise Value : | 5,360 Cr |
| Enter Prise Value Ebidta : | 56.514 |
| Forward PE : | 44.05 |
| Price Book MRQ : | 7.4 |
| Enter Prise Value Revenue : | 9.39 |
| Forward Annual Dividend Rate : | 0 |
| Payout Ratio : | 0 |
| Ex Dividend Date : | 2022-02-21 |
| Last Split Date : | 0000-00-00 |
| Forward Annual Dividend Yield : | 0 |
| Dividend Date : | |
| Last Split Factor : |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1658.2 | 1698.05 | 1726.05 | 1630.2 | 1590.35 | 1562.35 | 1522.5 |
| Fibonacci | 1676.9 | 1707.4 | 1744.75 | 1639.55 | 1609.05 | 1571.7 | 1541.2 |
| Camarilla | 1652.28 | 1695.09 | 1720.13 | 1627.24 | 1584.43 | 1559.39 | 1516.58 |
| Classic | 1701.53 | 1719.71 | 1769.38 | 1651.86 | 1633.68 | 1584.01 | 1565.83 |
| Days 50 Day MA |
1693.49 |
| Days 200 Day MA |
1782.01 |
| Days 52 Week High |
2200 |
| Days 52 Week Low |
1495.4 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Sep 2024 | 190 Cr | 24 Cr | 19 Cr | 161 Cr | 5 Cr | 7 Cr | 30 Cr | -5 Cr | 7 Cr |
| Jun 2024 | 128 Cr | 17 Cr | 4 Cr | 118 Cr | 5 Cr | 2 Cr | 11 Cr | -5 Cr | 2 Cr |
| Mar 2024 | 143 Cr | 21 Cr | 5 Cr | 131 Cr | 6 Cr | 2 Cr | 13 Cr | -6 Cr | 2 Cr |
| Dec 2023 | 118 Cr | 14 Cr | 10 Cr | 100 Cr | 6 Cr | 2 Cr | 18 Cr | -6 Cr | 2 Cr |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2024 | 581 Cr | 270 Cr | 56 Cr | 489 Cr | 22 Cr | 17 Cr | 1 Cr | -22 Cr | 17 Cr |
| Mar 2023 | 574 Cr | 169 Cr | 103 Cr | 438 Cr | 15 Cr | 37 Cr | 1 Cr | -15 Cr | 37 Cr |
| Mar 2022 | 316 Cr | 119 Cr | 61 Cr | 236 Cr | 3 Cr | 21 Cr | 3 Cr | -7 Cr | 21 Cr |
| Mar 2021 | 244 Cr | 93 Cr | 46 Cr | 173 Cr | 4 Cr | 19 Cr | 1 Cr | -7 Cr | 19 Cr |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Sep 2024 | 1,050 Cr | 582 Cr | 324 Cr | 350 Cr | 0 | 240 Cr | 700 Cr |
| Jun 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mar 2024 | 1,008 Cr | 565 Cr | 348 Cr | 331 Cr | 0 | 208 Cr | 676 Cr |
| Dec 2023 | 0 | 54 Cr | 0 | 0 | 0 | 0 | 661 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 1,008 Cr | 565 Cr | 348 Cr | 331 Cr | 0 | 208 Cr | 676 Cr |
| Mar 2023 | 1,063 Cr | 697 Cr | 387 Cr | 443 Cr | 0 | 342 Cr | 620 Cr |
| Mar 2022 | 728 Cr | 463 Cr | 170 Cr | 208 Cr | 17 Cr | 165 Cr | 520 Cr |
| Mar 2021 | 586 Cr | 399 Cr | 103 Cr | 110 Cr | 13 Cr | 89 Cr | 477 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Sep 2024 | 0 | 0 | 0 | 0 | 19 Cr | 0 | 0 |
| Jun 2024 | 0 | 0 | 0 | 0 | 4 Cr | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 | 0 | 5 Cr | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 | 0 | 10 Cr | 6 Cr | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2024 | 0 | 0 | 39 Cr | -56 Cr | 56 Cr | 23 Cr | 94 Cr |
| Mar 2023 | 0 | 0 | -216 Cr | -87 Cr | 140 Cr | 19 Cr | 108 Cr |
| Mar 2022 | 3 Cr | 18 Cr | -68 Cr | -57 Cr | 82 Cr | 14 Cr | 91 Cr |
| Mar 2021 | 12 Cr | 8 Cr | -27 Cr | -1 Cr | 65 Cr | 13 Cr | 23 Cr |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 1,901.45 | 1,906.25 | 1,912.95 | 1,920.65 |
1,928.30 |
1,936.05 | 1,942.80 | 1,947.60 |
| Date | Opening price | Closing price | Minimum price | Maximum price |
|---|---|---|---|---|
| 2025-01-15 | 1622 | 1629.65 | 1609.5 | 1647.65 |
| 2025-01-16 | 1647 | 1648.05 | 1620.15 | 1660 |
| 2025-01-17 | 1647 | 1691 | 1635.15 | 1698 |
| 2025-01-20 | 1694.95 | 1712.3 | 1681.2 | 1729.3 |
| 2025-01-21 | 1701 | 1682.9 | 1670 | 1718.85 |
MTAR Technologies Limited, a precision engineering solutions company, develops, manufactures, and sells high precision, heavy equipment, components, and machines in India and internationally. The company offers civilian nuclear power solution, which includes fuel machining head, drive mechanisms, bridge and column, hatch cover beam, coolant channel assemblies, grid plates, control plug, water lubricated bearings, and other products; clean energy solution; and structures, spiral casing, and rotar and stator assemblies for hydel, waste, energy, and other sectors, as well as manufactures electrolyser units. It also provides space solutions comprising electro-pneumatic modules; liquid propulsion engines; cryogenic upper stage assemblies, such as LOX and LH2 turbo pumps, injector heads, and gas generators; and ball screws. In addition, it offers aerospace solution, which includes weldment structures and high precision components; and defence products, including helicopter housing, magnesium gear boxes, dalia actuators, and aero structures, such as wing kit assemblies. Further, the company provides specialized products and import substitutes comprising electro-mechanical actuators, roller screws, valves, and ASP assemblies. MTAR Technologies Limited was founded in 1969 and is based in Hyderabad, India.
| Open | 1667.6 |
| LTP | 1618.35 |
| Previous Close | 1682.9 |
| Day High | 1670.05 |
| Day Low | 1602.2 |
| Volume | 121857 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Hindustan Aeron | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taneja Aerospac | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company WIPRO |
LTP 306.4 |
Change 8.05 |
Gain 2.7 % |
|
Company TCS |
LTP 4129.6 |
Change 93.75 |
Gain 2.32 % |
|
Company MARUTI |
LTP 11976.65 |
Change 92.95 |
Gain 0.78 % |
|
Company BHARTIARTL |
LTP 1635.45 |
Change 9.3 |
Gain 0.57 % |
|
Company HEROMOTOCO |
LTP 4047.75 |
Change 22.95 |
Gain 0.57 % |
|
Company TATAMOTORS |
LTP 739.75 |
Change -21 |
Loss -21 % |
|
Company SBIN |
LTP 747.75 |
Change -11.3 |
Loss -11.3 % |
|
Company TATASTEEL |
LTP 127.8 |
Change -1.9 |
Loss -1.9 % |
|
Company BPCL |
LTP 276.25 |
Change -3.95 |
Loss -3.95 % |
|
Company ONGC |
LTP 262.93 |
Change -2.87 |
Loss -2.87 % |
Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...
Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...
Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...
The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...
Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...
FSN E-Commerce Ventures inches up on incorporating Subsidiary Company
Login & Reply Like(0) Dislike(0) Repost Spam
Sandu Pharmaceuticals soars on incorporating wholly owned subsidiary
Login & Reply Like(0) Dislike(0) Repost Spam
today I entered at 1241 levels....will add more if it reaches 1200 levels...it is blind buy at CMP...
Login & Reply Like(0) Dislike(0) Repost Spam
Everytime the resistance level is coming down by more than 100 bucks!
Login & Reply Like(0) Dislike(0) Repost Spam
Guys soon there will be ofs in this counter. leave it before you regret. Cheers.
Login & Reply Like(0) Dislike(0) Repost Spam
best monopoly business ,fundamentally strong company, no issue with company and business dont panic and selling , good time to adding ,partnership with Isro and other big players
Login & Reply Like(0) Dislike(0) Repost Spam
2000 by end of July 22 buy buy
Login & Reply Like(0) Dislike(0) Repost Spam
INTRADAY01 2022-08-12 09:50:47
My estimate of EPS for the FY 23 is 28-30. If their design of SSLV is approved by ISRO, it will make every shareholder proud. Hold for ten years for 10X returns.
Login & Reply Like(0) Dislike(0) Repost Spam